Chery's New Brand - LEPAS Unveils First Vehicle, Redefining Elegant Mobility

ANQING, China, April 19, 2025 /PRNewswire/ -- On April 18, Chery achieved another milestone in its global strategy: LEPAS L8, the first vehicle under Chery's new international brand LEPAS, officially rolled off the production line. As a strategic move in Chery's premium positioning, LEPAS not only addresses a market gap but also redefines elegant mobility with its philosophy of "COLORFUL LIFE, MASTERFUL DRIVE."

With the audience watching in anticipation, Mr. Zhu Shaodong, Executive Vice President of Chery International, and Mr. Cao Bin, Chief Technology Officer of Chery, alongside other company leaders, unveiled LEPAS's first new vehicle—L8—revealing its sleek and elegant design in full for the first time. Representatives from global partners and media guests were present to witness this historic moment.

The launch of LEPAS marks the culmination of Chery's nearly three decades of automotive expertise and global capabilities. It aims to enrich users' lives through innovative technology and design while delivering a poised yet exhilarating driving experience. As a cornerstone of Chery's upmarket strategy, LEPAS transcends the car's functional role, transforming it into an expression of lifestyle aesthetics. The brand name fuses "LEAP" and "PASSION," symbolizing dynamism and vitality while balancing elegance with fervor. Its "Leopard Aesthetics" design creates boundary-defying visual signatures. Backed by Chery's eight global R&D centers, LEPAS reimagines "elegant control."

LEPAS L8, the brand's inaugural model, sets a new benchmark for mainstream SUVs. With its sleek styling, tech-forward cabin, spacious comfort, and comprehensive safety features, it caters to urban elites seeking a premium lifestyle. Beyond L8, LEPAS will expand its lineup to cover all mainstream segments, building a diverse product portfolio tailored to discerning customers - from family-oriented elites to those with refined tastes.

The LEPAS L8's debut heralds its global launch at 2025 Chery Business Conference in late April. Centered around the theme "COLORFUL LIFE, MASTERFUL DRIVE," the event will showcase the perfect fusion of elegance and technology to a worldwide audience. Amid the dual trends of automotive intelligence and consumption upgrades, the arrival of LEPAS represents not only a testament to Chery's technological prowess but also a bold reimagining of the future of mobility aesthetics. True to its vision—"Making LEPAS the choice for stylish, elegant mobility"—this journey, beginning in Wuhu, China, is now accelerating onto the world stage.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Chery's New Brand - LEPAS Unveils First Vehicle, Redefining Elegant Mobility

SEOUL, South Korea, Jan. 8, 2026 /PRNewswire/ -- STARMED, a pioneer in innovative minimally invasive treatment solutions, has announced a comprehensive rebranding. Now in its seventeenth year of operation, the company is formally transitioning from a Radiofrequency Ablation (RFA) specialist into a global multi-modality medical technology platform.

Established in 2009, STARMED pioneered the first thyroid-dedicated RFA electrode, effectively creating a clinical field that did not previously exist. This technology has since been adopted into various international clinical guidelines and continues to maintain the leading global market share today. Building on this heritage, STARMED has expanded its portfolio to address diverse clinical needs in liver, uterine, and vascular care, introducing various products such as the proprietary multi-electrode Octopus system. The current rebranding signals a strategic commitment to expand beyond RFA by integrating diverse energy sources, including Microwave Ablation (MWA) and Irreversible Electroporation (IRE), into a unified therapeutic offering.

"With the global thermal ablation market projected to reach $2 billion by 2033, this rebranding is a pivotal step for our next stage of growth," said CEO Henry Shin.

The newly unveiled Corporate Identity reflects both STARMED's heritage and its future vision. The symbol represents technical precision by visualising the initial 'S' alongside the silhouette of an electrode tip. This reflects a dedication to minimising patient pain and providing care throughout the recovery process. The wordmark employs a sophisticated, futuristic typeface to reinforce trust within the global healthcare arena.

Supported by strong financial foundations, STARMED plans to capitalise on a market growing at 10.5% annually. The company remains committed to establishing minimally invasive treatments as the global 'Standard of Care' through enhanced clinical partnerships.

About STARMED

STARMED is a medical device specialist founded in 2009. With more than 660 clinical research evidence, the company provides world-class thermal ablation solutions to over 70 countries and continues to advance minimally invasive treatment as the clinical standard.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy